PL4043451T3 - Sposoby wytwarzania związku pośredniego w syntezie kwasu 5-bromo-2-(3-chloropirydyn-2-ylo)-2h-pirazolo-3-karboksylowego - Google Patents

Sposoby wytwarzania związku pośredniego w syntezie kwasu 5-bromo-2-(3-chloropirydyn-2-ylo)-2h-pirazolo-3-karboksylowego

Info

Publication number: PL4043451T3
Authority: PL; Poland
Prior art keywords: ylo; chloropyridin; pyrazolo; bromo; synthesis
Prior art date: 2019-10-18

Application number

PL22161905.9T

Other languages

English (en)

Inventor

Yanchun Cao

Xin Liu

Jianhua Mao

Zhijian Xu

Original Assignee

Fmc Corporation

Fmc Agro Singapore Pte. Ltd.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2019-10-18

Filing date

2020-10-16

Publication date

2024-06-10

2020-10-16 Application filed by Fmc Corporation, Fmc Agro Singapore Pte. Ltd. filed Critical Fmc Corporation

2024-06-10 Publication of PL4043451T3 publication Critical patent/PL4043451T3/pl

Links

230000015572 biosynthetic process Effects 0.000 title 1
238000000034 method Methods 0.000 title 1
238000003786 synthesis reaction Methods 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/16—Halogen atoms or nitro radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Plural Heterocyclic Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PL22161905.9T 2019-10-18 2020-10-16 Sposoby wytwarzania związku pośredniego w syntezie kwasu 5-bromo-2-(3-chloropirydyn-2-ylo)-2h-pirazolo-3-karboksylowego PL4043451T3 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201962916840P	2019-10-18	2019-10-18
US202062982248P	2020-02-27	2020-02-27

Publications (1)

Publication Number	Publication Date
PL4043451T3 true PL4043451T3 (pl)	2024-06-10

Family

ID=73198483

Family Applications (4)

Application Number	Title	Priority Date	Filing Date
PL20804069.1T PL3976589T3 (pl)	2019-10-18	2020-10-16	Sposoby wytwarzania kwasu 5-bromo-2-(3-chloropirydyn-2-ylo)-2H-pirazolo-3-karboksylowego
PL20804381.0T PL3976591T3 (pl)	2019-10-18	2020-10-16	Sposoby wytwarzania kwasu 5-bromo-2-(3-chloropirydyn-2-ylo)-2h- pirazolo-3-karboksylowego
PL23166843.5T PL4219455T3 (pl)	2019-10-18	2020-10-16	Sposób wytwarzania fluorowcowanego pirazolu
PL22161905.9T PL4043451T3 (pl)	2019-10-18	2020-10-16	Sposoby wytwarzania związku pośredniego w syntezie kwasu 5-bromo-2-(3-chloropirydyn-2-ylo)-2h-pirazolo-3-karboksylowego

Family Applications Before (3)

Application Number	Title	Priority Date	Filing Date
PL20804069.1T PL3976589T3 (pl)	2019-10-18	2020-10-16	Sposoby wytwarzania kwasu 5-bromo-2-(3-chloropirydyn-2-ylo)-2H-pirazolo-3-karboksylowego
PL20804381.0T PL3976591T3 (pl)	2019-10-18	2020-10-16	Sposoby wytwarzania kwasu 5-bromo-2-(3-chloropirydyn-2-ylo)-2h- pirazolo-3-karboksylowego
PL23166843.5T PL4219455T3 (pl)	2019-10-18	2020-10-16	Sposób wytwarzania fluorowcowanego pirazolu

Country Status (17)

Country	Link
US (2)	US20220396560A1 (pl)
EP (5)	EP3976591B1 (pl)
JP (2)	JP7667144B2 (pl)
KR (2)	KR20220086612A (pl)
CN (3)	CN114650987B (pl)
AU (2)	AU2020366212A1 (pl)
BR (2)	BR112022007102A2 (pl)
HU (4)	HUE062237T2 (pl)
IL (5)	IL298694B2 (pl)
MA (2)	MA56055A (pl)
MX (2)	MX2022004631A (pl)
PL (4)	PL3976589T3 (pl)
PY (1)	PY2065468A (pl)
TW (3)	TWI875840B (pl)
UY (1)	UY38925A (pl)
WO (2)	WO2021076839A1 (pl)
ZA (2)	ZA202204278B (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2020366425A1 (en) *	2019-10-18	2022-04-21	Fmc Corporation	Methods for the preparation of 5-Bromo-2-(3-chloro-pyridin-2-yl)-2H-pyrazole-3-carboxylic acid
EP3976591B1 (en) *	2019-10-18	2023-04-19	FMC Corporation	Methods for the preparation of 5-bromo-2-(3-chloro-pyridin-2-yl)-2h-pyrazole-3-carboxylic acid
CN115557931B (zh) *	2022-10-20	2024-05-14	浙江新安化工集团股份有限公司	一种3-溴-1-(3-氯-2-吡啶基)-1h-吡唑-5-甲酸的合成方法
CN117024374A (zh) *	2023-08-08	2023-11-10	安庆百谊生物科技有限公司	一种3-甲基-1，2，4-噻二唑-5-碳酰肼或其盐的合成方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2060816C3 (de) *	1970-12-10	1980-09-04	Merck Patent Gmbh, 6100 Darmstadt	4-Phenylpiperidinderivate Verfahren zu ihrer Herstellung und pharmazeutische Zubereitungen enthaltend diese Verbindungen
DE3011084A1 (de) *	1980-03-22	1981-10-01	Bayer Ag, 5090 Leverkusen	Verfahren zur herstellung von substituierten n-azolylmethyl-halogenacetaniliden
JPH07110867B2 (ja) *	1987-04-04	1995-11-29	株式会社トクヤマ	ハロゲン化複素環式化合物の製造方法
TWI312274B (en)	2001-08-13	2009-07-21	Du Pont	Method for controlling particular insect pests by applying anthranilamide compounds
ES2424840T3 (es) *	2003-01-28	2013-10-09	E.I. Du Pont De Nemours And Company	Insecticidas tipo ciano antranilamida
PE20060285A1 (es) *	2004-03-30	2006-05-08	Aventis Pharma Inc	Piridonas sustituidas como inhibidores de pol(adp-ribosa)-polimerasa (parp)
MY140912A (en) *	2004-07-26	2010-01-29	Du Pont	Mixtures of anthranilamide invertebrate pest control agents
US7087755B1 (en) *	2004-11-12	2006-08-08	Frontier Scientific, Inc.	Substituted pyridines
ATE556055T1 (de) *	2006-12-13	2012-05-15	Pfizer Prod Inc	Verfahren zur herstellung von 3-(4-(2,4- difluorbenzyloxy)-3-brom-6-methyl- 2-oxopyridin- 1(2h)-yl)-n,4-dimethylbenzamid
CL2008000979A1 (es) *	2007-04-11	2008-10-17	Sumitomo Chemical Co	Proceso para producir un compuesto derivado de 2-piridin-2-il-2h-pirazol-3-fenilamida; compuestos intermediarios; el compuesto en si; composicion plaguicida que contiene a dicho compuesto; uso de dicho compuesto como plaguicida; y metodo para control
JP2008280340A (ja) *	2007-04-12	2008-11-20	Sumitomo Chemical Co Ltd	ヒドラジド化合物及びそれを含有する有害節足動物防除剤
JP2009023991A (ja) *	2007-06-20	2009-02-05	Ishihara Sangyo Kaisha Ltd	アントラニルアミド系化合物の製造方法
CN102746327A (zh) *	2007-08-14	2012-10-24	住友化学株式会社	肼化合物的制造方法、以及肼化合物的制造中间体及其制造方法
TW201245155A (en) *	2010-09-01	2012-11-16	Du Pont	Fungicidal pyrazoles
CN102651485B (zh) *	2011-02-28	2016-03-30	丰田自动车株式会社	可充镁电池、电解液在可充镁电池中的应用、以及用于可充镁电池的电解液
WO2012167606A1 (zh) *	2011-06-04	2012-12-13	山东亨利医药科技有限责任公司	吡啶并萘啶类PI3K和mTOR双重抑制剂及其制备与应用
WO2013105100A1 (en) *	2012-01-09	2013-07-18	Symed Labs Limited	Processes for the preparation of 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophene-carboxamide and intermediates thereof
HRP20191755T1 (hr) *	2012-09-07	2019-12-27	Boehringer Ingelheim International Gmbh	Alkoksipirazoli kao aktivatori topljive gvanilat ciklaze
CN105669643A (zh) *	2013-12-05	2016-06-15	江西天人生态股份有限公司	一类基于鱼泥丁受体的邻甲酰氨基苯甲酰胺衍生物及其制备方法和用途
EP3495360A1 (en) *	2014-04-14	2019-06-12	Grünenthal GmbH	Heteroaryl substituted heterocyclyl sulfones
TW201726128A (zh) *	2015-10-08	2017-08-01	歌林達有限公司	經吡唑基取代之四氫哌喃基碸
EP3371176A4 (en) *	2015-10-16	2019-09-04	William Marsh Rice University	EPOTHILON ANALOGUE, SYNTHESIS METHOD, TREATMENT METHOD AND MEDICAMENT CONJUGATE THEREFOR
KR102522231B1 (ko) *	2016-12-21	2023-04-14	바이엘 크롭사이언스 악티엔게젤샤프트	2-피리딜에틸카복사미드 유도체의 제조 방법
GB201721969D0 (en) *	2017-12-27	2018-02-07	Bp Oil Int	Methods for preparing fuel additives
CN111825653A (zh) *	2019-04-19	2020-10-27	安道麦马克西姆有限公司	取代吡唑类化合物的制备及其作为邻氨基苯甲酰胺前体的用途
EP3976591B1 (en)	2019-10-18	2023-04-19	FMC Corporation	Methods for the preparation of 5-bromo-2-(3-chloro-pyridin-2-yl)-2h-pyrazole-3-carboxylic acid

2020
- 2020-10-16 EP EP20804381.0A patent/EP3976591B1/en active Active
- 2020-10-16 CN CN202080072845.5A patent/CN114650987B/zh active Active
- 2020-10-16 WO PCT/US2020/055897 patent/WO2021076839A1/en not_active Ceased
- 2020-10-16 PL PL20804069.1T patent/PL3976589T3/pl unknown
- 2020-10-16 HU HUE20804381A patent/HUE062237T2/hu unknown
- 2020-10-16 MA MA056055A patent/MA56055A/fr unknown
- 2020-10-16 MX MX2022004631A patent/MX2022004631A/es unknown
- 2020-10-16 HU HUE20804069A patent/HUE062047T2/hu unknown
- 2020-10-16 IL IL298694A patent/IL298694B2/en unknown
- 2020-10-16 US US17/769,810 patent/US20220396560A1/en not_active Abandoned
- 2020-10-16 TW TW109135805A patent/TWI875840B/zh active
- 2020-10-16 CN CN202080072852.5A patent/CN114641471B/zh active Active
- 2020-10-16 AU AU2020366212A patent/AU2020366212A1/en not_active Abandoned
- 2020-10-16 UY UY0001038925A patent/UY38925A/es unknown
- 2020-10-16 EP EP20804069.1A patent/EP3976589B1/en active Active
- 2020-10-16 TW TW109135811A patent/TWI884994B/zh active
- 2020-10-16 PL PL20804381.0T patent/PL3976591T3/pl unknown
- 2020-10-16 JP JP2022521265A patent/JP7667144B2/ja active Active
- 2020-10-16 PL PL23166843.5T patent/PL4219455T3/pl unknown
- 2020-10-16 US US17/769,787 patent/US20220259178A1/en not_active Abandoned
- 2020-10-16 IL IL294551A patent/IL294551B2/en unknown
- 2020-10-16 CN CN202411157026.7A patent/CN119039270A/zh active Pending
- 2020-10-16 MX MX2022004627A patent/MX2022004627A/es unknown
- 2020-10-16 BR BR112022007102A patent/BR112022007102A2/pt not_active Application Discontinuation
- 2020-10-16 BR BR112022007215A patent/BR112022007215A2/pt not_active Application Discontinuation
- 2020-10-16 AU AU2020366037A patent/AU2020366037A1/en not_active Abandoned
- 2020-10-16 WO PCT/US2020/055888 patent/WO2021076835A1/en not_active Ceased
- 2020-10-16 HU HUE23166843A patent/HUE070680T2/hu unknown
- 2020-10-16 EP EP22161905.9A patent/EP4043451B1/en active Active
- 2020-10-16 KR KR1020227016245A patent/KR20220086612A/ko not_active Ceased
- 2020-10-16 EP EP23166843.5A patent/EP4219455B1/en active Active
- 2020-10-16 MA MA056053A patent/MA56053A/fr unknown
- 2020-10-16 JP JP2022521266A patent/JP2022552273A/ja active Pending
- 2020-10-16 IL IL291939A patent/IL291939B2/en unknown
- 2020-10-16 PY PY202002065468A patent/PY2065468A/es unknown
- 2020-10-16 TW TW113140016A patent/TW202517625A/zh unknown
- 2020-10-16 HU HUE22161905A patent/HUE066520T2/hu unknown
- 2020-10-16 KR KR1020227016372A patent/KR20220084347A/ko not_active Ceased
- 2020-10-16 PL PL22161905.9T patent/PL4043451T3/pl unknown
- 2020-10-16 IL IL299818A patent/IL299818B2/en unknown
- 2020-10-16 EP EP23168298.0A patent/EP4253380A3/en not_active Withdrawn
2022
- 2022-04-10 IL IL292090A patent/IL292090B2/en unknown
- 2022-04-14 ZA ZA2022/04278A patent/ZA202204278B/en unknown
- 2022-04-14 ZA ZA2022/04277A patent/ZA202204277B/en unknown

Also Published As

Publication number	Publication date
EP4253380A3 (en)	2023-11-15
PL3976591T3 (pl)	2023-07-31
CN114650987A (zh)	2022-06-21
EP4043451A1 (en)	2022-08-17
CN114641471B (zh)	2025-05-23
IL294551B2 (en)	2023-05-01
HUE062047T2 (hu)	2023-09-28
HUE070680T2 (hu)	2025-06-28
JP2022552272A (ja)	2022-12-15
IL294551B1 (en)	2023-01-01
HUE066520T2 (hu)	2024-08-28
JP2022552273A (ja)	2022-12-15
CN114641471A (zh)	2022-06-17
TWI875840B (zh)	2025-03-11
WO2021076835A8 (en)	2021-11-04
AU2020366212A1 (en)	2022-04-21
CN119039270A (zh)	2024-11-29
TWI884994B (zh)	2025-06-01
WO2021076839A1 (en)	2021-04-22
KR20220086612A (ko)	2022-06-23
ZA202204278B (en)	2024-08-28
AU2020366037A1 (en)	2022-04-21
EP3976591A1 (en)	2022-04-06
EP4043451B1 (en)	2024-02-28
IL294551A (en)	2022-09-01
IL299818B1 (en)	2024-10-01
EP3976589A1 (en)	2022-04-06
CN114650987B (zh)	2024-09-06
TW202517625A (zh)	2025-05-01
PL4219455T3 (pl)	2025-04-14
TW202116748A (zh)	2021-05-01
US20220396560A1 (en)	2022-12-15
IL299818B2 (en)	2025-02-01
IL299818A (en)	2023-03-01
WO2021076835A1 (en)	2021-04-22
MA56055A (fr)	2022-04-06
EP4219455B1 (en)	2024-12-11
EP4219455A1 (en)	2023-08-02
IL291939A (en)	2022-06-01
PL3976589T3 (pl)	2023-07-31
UY38925A (es)	2021-05-31
MA56053A (fr)	2022-04-20
IL291939B2 (en)	2023-04-01
TW202128631A (zh)	2021-08-01
IL298694B1 (en)	2025-01-01
MX2022004631A (es)	2022-05-24
IL298694B2 (en)	2025-05-01
MX2022004627A (es)	2022-05-26
PY2065468A (es)	2023-05-16
EP3976589B1 (en)	2023-04-12
IL292090B2 (en)	2023-06-01
KR20220084347A (ko)	2022-06-21
BR112022007215A2 (pt)	2022-07-05
IL298694A (en)	2023-02-01
IL292090A (en)	2022-06-01
JP7667144B2 (ja)	2025-04-22
EP3976591B1 (en)	2023-04-19
BR112022007102A2 (pt)	2022-07-05
US20220259178A1 (en)	2022-08-18
EP4253380A2 (en)	2023-10-04
IL291939B (en)	2022-12-01
ZA202204277B (en)	2024-08-28
HUE062237T2 (hu)	2023-10-28

Publication	Publication Date	Title
IL268525A (en)	2019-09-26	Mammalian cells for producing adeno-associated viruses
EP3645146A4 (en)	2021-05-05	SYNTHESIS OF OLIGOSACCHARIDES
EP2971033A4 (en)	2016-11-16	METHOD OF MANUFACTURING RNA TRANSCRIPTS
PL4043451T3 (pl)	2024-06-10	Sposoby wytwarzania związku pośredniego w syntezie kwasu 5-bromo-2-(3-chloropirydyn-2-ylo)-2h-pirazolo-3-karboksylowego
EP4019200A4 (en)	2023-10-04	Production system
EP3390652C0 (en)	2024-12-04	PRODUCTION OF OLIGOSACCHARIDES BY FERMENTATION
HUE067017T2 (hu)	2024-09-28	Eljárás poliolok gyártására
HUE057926T2 (hu)	2022-06-28	Eljárás tiokarbonátok elõállítására
PL3608301T3 (pl)	2023-05-08	Sposób wytwarzania podłoża uprawowego
EP3589623C0 (en)	2023-06-07	PREPARATION OF DICARBOXYLIC ACID FROM 2,5-FURAN
EP3808783A4 (en)	2022-03-16	Novel crosslinked alginic acid
PL3460102T3 (pl)	2021-05-04	Sposób wytwarzania elektrokatalizatora
EP3506254A4 (en)	2019-11-27	SOUNDPROOF STRUCTURE
IL284374A (en)	2021-08-31	Methods of producing ustekinumab
EP3799594A4 (en)	2022-06-15	PRODUCTION OF OLIGOSACCHARIDS
SI3679010T1 (sl)	2022-04-29	Adukti ogljikove kisline
EP3778653C0 (en)	2025-07-09	NEW REACTIVE ALGINIC ACID DERIVATIVES
EP4049824A4 (en)	2023-12-06	MOLD
EP3358960A4 (en)	2019-07-03	OIL COMPOSITIONS AND METHOD OF PREPARING THEREOF
HUE060213T2 (hu)	2023-02-28	Javított eljárások T-sejtek elõállítására
PL3355870T3 (pl)	2021-07-05	Sposób wytwarzania kompresowanych tabletek
EP3344280A4 (en)	2019-05-01	EDUCATION OF BONE
PL3497225T3 (pl)	2022-03-21	Sposób wytwarzania kwasu mlekowego
EP3336612A4 (en)	2019-06-26	HOLOGRAM STRUCTURE
HRP20190286T1 (hr)	2019-04-05	Postupci za pripremu spojeva, kao što su 3-arilbutanali, korisni u sintezi medetomidina